GlassScriptPhysician profile
James M Stevens
NPI 1265680730
$5,534.06
in general payments reported to CMS, 2019-2025
11 companies · $277 in 2025
The $277 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $118 · 2020: $146 · 2021: $256 · 2022: $4,468 · 2023: $100 · 2024: $169 · 2025: $277.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $546.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $546.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,018.83 | 2019-2025 | Da Vinci Surgical System |
| Medtronic, INC. | $174.57 | 2022-2025 | Transorb, Signia, Gia |
| Davol INC. | $90.41 | 2020-2022 | |
| Stryker Corporation | $59.04 | 2022 | |
| Becton, Dickinson and Company | $50.85 | 2024 | Phasix Mesh |
| Innovation Technologies INC | $34.49 | 2025 | Irrisept |
| Olympus America INC. | $22.94 | 2022 | |
| Ethicon US, LLC | $22.28 | 2019 | |
| Integra Lifesciences Corporation | $21.78 | 2023 | Integra, Surgimend, Omnigraft |
| Innocoll Pharmaceuticals Limited | $20.09 | 2022 | |
| Abbvie INC. | $18.78 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Stevens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.